---
created: 2025-04-13
updated: 2025-04-13T10:51
id: zpmLOJ@}S0
specialty: endo
specialty_id: 1
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/amboss::
  - theme/self-assesment
  - source/ak-step1-v11::
  - theme/b&b::09-gi::02-physiology::04-gastrointestinal-hormones
  - source/ak-step1-v11::
  - theme/firstaid::08-endocrine::05-pharm::04-hypothalamic-pituitary-drugs
  - source/ak-step1-v11::
  - theme/firstaid::08-endocrine::05-pharm::04-hypothalamic-pituitary-drugs::octreotide
  - source/ak-step1-v11::
  - theme/firstaid::09-gastrointestinal::05-pharm::07-octreotide
  - source/ak-step1-v11::
  - theme/firstaid::09-gastrointestinal::05-pharm::09-loperamide-diphenoxylate
  - source/ak-step1-v11::
  - theme/nbme::29
  - source/ak-step1-v11::
  - theme/nbme::30
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::11-gastrointestinal
  - source/ak-step1-v11::
  - source/ome-banner::clinical::20-primer:-methods-for-success
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::11-gastrointestinal::06-octreotide
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::11-gastrointestinal::12-laxatives
  - source/ak-step1-v11::
  - theme/physeo::11-pathology::02-endocrine-pathology::06-endocrine-pancreas
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::09-gi::octreotide
  - source/ak-step1-v11::
  - theme/sketchypharm::05-gi-&-endocrine::01-gi::06-laxatives-&-antidiarrheal-agents
  - source/ak-step1-v11::
  - theme/sketchypharm::05-gi-&-endocrine::04-hypothalamic-&-pituitary::01-growth-hormone,-mecasermin,-octreotide,-pegvisomant
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::endocrine::pharmacology
  - source/ak-step1-v11::^systems::gi::pharm
  - source/ak-step2-v11::!shelf::surgery
  - source/ak-step2-v11::!shelf::surgery::no-dupes
  - source/ak-step2-v11::
  - source/ome-banner::clinical::20-primer:-methods-for-success
  - source/ak-step2-v11::
  - theme/resources-by-rotation::surgery::emma
  - source/ak-step2-v11::
  - theme/subjects::endocrinology::06-pancreas::endocrine-neoplasms::vipoma
  - source/ak-step2-v11::
  - theme/subjects::gastroenterology::04-stomach::carcinoid-syndrome
  - source/ak-step2-v11::
  - theme/uworld::1000-9999::2000-2999::2220
  - source/ak-step2-v11::original-decks::dorian::surg::emma
type: flashcard
---

# Question
**Octreotide = somatostatin analog** = may be used to treat the secretory diarrhea caused by VIPoma and carcinoid syndrome

---

# Answer
octreotide may also be used for acute variceal bleeds and other secretory diarrheas, eg. chemotherapy and HIV-induced diarrhea, and short bowel syndrome   VIPomas = WDHA syndrome (watery diarrhea, hypoKalemia, achlorhydria); parasympathetic release of vasoactive intestinal polypeptide (VIP) == == inc GI secretion of H2O and electrolytes + inc relaxation of GI smooth mm fibers